Antenatal Magnesium Sulfate Benefits Female Preterm Infants but Results in Poor Male Outcomes.

Authors:
McLeod RM; Rosenkrantz TS; Fitch RH.

Journal:
Pharmaceuticals (Basel)

Publication Year: 2024

DOI:
10.3390/ph17020218

PMCID:
PMC10892166

PMID:
38399433

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Pharmaceuticals (Basel)

Abbreviation: Pharmaceuticals (Basel)

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
1,2,4-Triazole-Tethered Indolinones as New Cancer-Fighting Small Molecules Targeting VEGFR-2: Synth…
Elsawi AE; Shahin MI; Elbendary HA and 3 more (2024) - Transparency Score: 3/6
2023 FDA TIDES (Peptides and Oligonucleotides) Harvest.
Al Shaer D; Al Musaimi O; Albericio F and 1 more (2024) - Transparency Score: 3/6
Accelerated Neuroimmune Dysfunction in Aged HIV-1-Infected Humanized Mice.
Zhang C; Su H; Waight E and 4 more (2024) - Transparency Score: 3/6
A Comparison of the Anxiolytic Properties of Tofisopam and Diazepam: A Double-Blind, Randomized, Cr…
Kokoszka A. (2024) - Transparency Score: 3/6
A Comprehensive Immunocapture-LC-MS/MS Bioanalytical Approach in Support of a Biotherapeutic Ocular…
Chen LZ; Roos D; Philip E and 4 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest The authors declare no conflicts of interest."

Evidence found in paper:

"This material is based upon work supported by the National Science Foundation under Grant DGE-1747486."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025